entertainment -WSS

entertainment

author：fashion 2025-09-28 02:30:33 - browse：3

a stethoscope and money – hospitals and health insurance coverage from STAT — Bright Health is officially leaving the health insurance market. The company has agreed to sell its Medicare Advantage plans to Molina Healthcare. Adobe

Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded peer Molina Healthcare.

Regulators must approve the deal. But the pending sale of its Medicare Advantage business means the financially distressed Bright has exited the health insurance market that the company was founded on. It will solely operate roughly 70 physician clinics located in California, Texas, and Florida.

Molina agreed to pay $600 million for Bright’s 125,000 California Medicare Advantage enrollees, which equates to about $4,800 for each person. The federal government paid insurance companies almost $12,000, on average, for each MA enrollee in 2022. Molina said in a news release that Bright’s current book of business generates $1.8 billion of revenue, or more than $14,000 for each member.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Van's Gluten Free Original Waffles recalled for possible wheat allergen

hotspot

WSS

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Brain 'hot spot' may explain why African Americans feel greater pain

Pfizer's Covid pill remains 89% effective in final analysis, company says

A new study asks: Are we harming blood donors by taking blood?

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Radiology is caught between AI's potential and concern for patients

focus

entertainment

Wikipedia

Cancer drug shortages should be causing more outrage

What causes an itch? Researchers may have solved the mystery

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Pfizer's Covid pill remains 89% effective in final analysis, company says

Hollywood unions extend contract negotiations for actors

Grail is spending more than ever lobbying Congress

Sports medicine is finally prioritizing gender equality

Roche to buy Carmot Therapeutics, developer of obesity drugs

In age of alternative facts, a scholarly course on calling out crap

FDA needs staff influx to meet gene therapy needs, Marks says

focus

AI models in health care face new federal disclosure requirements

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Connecting traumatic brain injury and domestic violence

7 people shot in DC, police say

Grail is spending more than ever lobbying Congress

SCOTUS to consider access to abortion pill mifepristone

entertainment

focus

hotspot

hotspot